Neostigmine



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Neuromuscular Blockade Reversal 22.7%
Drug Use For Unknown Indication 13.6%
Induction Of Anaesthesia 13.6%
Abdominal Distension 6.8%
Ileus 6.8%
Adverse Event 4.5%
Prophylaxis 4.5%
Anaesthesia Reversal 2.3%
Colonic Pseudo-obstruction 2.3%
General Anaesthesia 2.3%
Haemorrhage Prophylaxis 2.3%
Hypertension 2.3%
Infection Prophylaxis 2.3%
Intestinal Functional Disorder 2.3%
Intestinal Obstruction 2.3%
Neurogenic Bowel 2.3%
Obstruction 2.3%
Prophylaxis Of Nausea And Vomiting 2.3%
Thrombosis Prophylaxis 2.3%
Tachycardia 18.2%
Drug Ineffective 9.1%
Medication Error 9.1%
Respiratory Arrest 9.1%
Bronchospasm 4.5%
Coagulopathy 4.5%
Electromechanical Dissociation 4.5%
Heart Rate Increased 4.5%
Hyperhidrosis 4.5%
Large Intestine Perforation 4.5%
Muscular Weakness 4.5%
Pancreatitis 4.5%
Procedural Complication 4.5%
Urticaria 4.5%
Wound Infection 4.5%
Wrong Drug Administered 4.5%
Secondary
Drug Use For Unknown Indication 24.4%
Anaesthesia 17.9%
Product Used For Unknown Indication 12.3%
Anaesthesia Procedure 6.1%
General Anaesthesia 5.2%
Neuromuscular Blockade Reversal 4.5%
Maintenance Of Anaesthesia 4.2%
Induction Of Anaesthesia 4.0%
Hypertension 2.5%
Sedation 2.5%
Anaesthesia Reversal 2.3%
Blood Pressure Increased 2.2%
Premedication 1.8%
Neuromuscular Blockade 1.6%
Prophylaxis 1.6%
Vitamin Supplementation 1.6%
Hypotension 1.4%
Tachycardia 1.4%
Endotracheal Intubation 1.3%
Atrial Fibrillation 1.1%
Cardiac Arrest 15.3%
Toxic Epidermal Necrolysis 8.5%
Conversion Disorder 6.8%
Tachycardia 6.8%
Tachypnoea 6.8%
Completed Suicide 5.1%
Drug Interaction 5.1%
Renal Failure Acute 5.1%
Serotonin Syndrome 5.1%
Chylothorax 3.4%
Electrocardiogram St Segment Elevation 3.4%
Laryngeal Oedema 3.4%
Laryngospasm 3.4%
Oxygen Saturation Decreased 3.4%
Product Deposit 3.4%
Torsade De Pointes 3.4%
Unresponsive To Stimuli 3.4%
Ventricular Tachycardia 3.4%
Wound Infection 3.4%
Acute Respiratory Distress Syndrome 1.7%
Concomitant
Drug Use For Unknown Indication 28.2%
Product Used For Unknown Indication 15.3%
Anaesthesia 9.1%
Pain 5.3%
Induction Of Anaesthesia 4.7%
Hypertension 4.6%
General Anaesthesia 4.3%
Supplementation Therapy 3.9%
Maintenance Of Anaesthesia 3.3%
Sedation 2.8%
Psoas Abscess 2.7%
Neuromuscular Blockade Reversal 2.5%
Thrombosis Prophylaxis 2.3%
Acute Coronary Syndrome 2.0%
Premedication 1.9%
Intraoperative Care 1.7%
Anaesthesia Reversal 1.5%
Epilepsy 1.4%
Antibiotic Prophylaxis 1.4%
Catheterisation Cardiac 1.3%
Tremor 9.5%
Unresponsive To Stimuli 7.1%
Vomiting 7.1%
Respiratory Disorder 6.3%
Septic Shock 6.3%
Thrombocytopenia 6.3%
Pulmonary Embolism 5.6%
Serotonin Syndrome 5.6%
White Blood Cell Count Increased 5.6%
Post Procedural Complication 4.8%
Upper Respiratory Tract Infection 4.8%
Fatigue 4.0%
Stevens-johnson Syndrome 4.0%
Tongue Oedema 4.0%
Dystonia 3.2%
Neuromuscular Block Prolonged 3.2%
Renal Failure Acute 3.2%
Skin Ulcer 3.2%
Somnolence 3.2%
Swollen Tongue 3.2%
Interacting
Anaesthesia Procedure 47.4%
Induction Of Anaesthesia 26.3%
Product Used For Unknown Indication 21.1%
Benign Prostatic Hyperplasia 5.3%
Atrioventricular Dissociation 33.3%
Drug Interaction 33.3%
Unwanted Awareness During Anaesthesia 33.3%